Cargando…
Evaluation of risk for graft-versus-host disease in children who receive less than the full doses of mini-dose methotrexate for graft-versus-host disease prophylaxis in allogeneic hematopoietic stem cell transplantation
PURPOSE: The use of cyclosporine and mini-dose methotrexate (MTX) is a common strategy for graft-versus-host disease (GVHD) prophylaxis in allogeneic transplants. We investigated whether patients who receive fewer than the planned MTX doses are at increased risk for GVHD. METHODS: The study cohort i...
Autores principales: | Yum, Sook Kyung, Choi, Hye-Yoon, Lee, Jae Wook, Jang, Pil-Sang, Chung, Nack-Gyun, Jeong, Dae-Chul, Cho, Bin, Kim, Hack-Ki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Pediatric Society
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3859882/ https://www.ncbi.nlm.nih.gov/pubmed/24348662 http://dx.doi.org/10.3345/kjp.2013.56.11.490 |
Ejemplares similares
-
Tacrolimus/methotrexate vs tacrolimus/reduced-dose methotrexate/mycophenolate for graft-versus-host disease prevention
por: Hamilton, Betty K., et al.
Publicado: (2023) -
Prognostic Implications of the NIH Consensus Criteria in Children with Chronic Graft-versus-Host Disease
por: Lee, Jae Wook, et al.
Publicado: (2011) -
The development of graft-versus-host disease prophylaxis
por: Cutler, Corey
Publicado: (2023) -
Methotrexate for the Treatment of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation
por: Nassar, Amr, et al.
Publicado: (2014) -
Oral mucositis after tacrolimus/sirolimus or cyclosporine/methotrexate as graft‐versus‐host disease prophylaxis
por: Garming Legert, Karin, et al.
Publicado: (2020)